Foresite Capital Fund V L.P. 13D and 13G filings for Cullinan Oncology, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2022-02-11 3:05 pm Sale | 2021-12-31 | 13G | Cullinan Oncology, Inc. CGEM | Foresite Capital Fund V L.P. | 1,524,008 3.500% | -2,117,871 (-58.15%) | Filing |
| 2021-01-15 06:05 am Purchase | 2021-01-08 | 13G | Cullinan Oncology, Inc. CGEM | Foresite Capital Fund V L.P. | 3,641,879 8.800% | 3,641,879 (New Position) | Filing |